Net profit of Venus Remedies rose 473.50% to Rs 20.13 crore in the quarter ended September 2025 as against Rs 3.51 crore during the previous quarter ended September 2024. Sales rose 13.32% to Rs 192.75 crore in the quarter ended September 2025 as against Rs 170.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales192.75170.10 13 OPM %16.064.45 - PBDT32.6615.48 111 PBT26.499.07 192 NP20.133.51 474 Powered by Capital Market - Live News

Venus Remedies will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live News

Net profit of Venus Remedies rose 686.89% to Rs 9.60 crore in the quarter ended June 2025 as against Rs 1.22 crore during the previous quarter ended June 2024. Sales rose 21.44% to Rs 131.90 crore in the quarter ended June 2025 as against Rs 108.61 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales131.90108.61 21 OPM %7.6610.37 - PBDT18.7812.83 46 PBT12.606.85 84 NP9.601.22 687 Powered by Capital Market - Live News

Venus Remedies will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live News

Venus Remedies announced that the 36th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live News